Due to a production error, the positions of Li Zhang and Yue Zhang were misplaced in the author list, which should be as follows:
Yue Zhang1†, Shengjun Li2†, Rongrong Li3, Xu Qiu1, Tianyu Fan4, Bin Wang1, Bei Zhang1 and Li Zhang1*.
The publisher apologizes for this mistake.
The original version of this article has been updated.
Summary
Keywords
CRISPR-Cas system, CRISPR-Cas13a, genome editing, molecular diagnosis, gene therapy
Citation
Frontiers Production Office (2024) Erratum: Advances in application of CRISPR-Cas13a system. Front. Cell. Infect. Microbiol. 14:1393044. doi: 10.3389/fcimb.2024.1393044
Received
28 February 2024
Accepted
28 February 2024
Published
08 March 2024
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
14 - 2024
Updates
Copyright
© 2024 Frontiers Production Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, production.office@frontiersin.org
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.